blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2448910

EP2448910 - METHOD OF PREPARING NERAMEXANE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  21.03.2014
Database last updated on 03.10.2024
Most recent event   Tooltip12.10.2018Lapse of the patent in a contracting state
New state(s): AL		published on 14.11.2018  [2018/46]
Applicant(s)For all designated states
Merz Pharma GmbH & Co. KGaA
Eckenheimer Landstrasse 100
60318 Frankfurt Main / DE
[2012/19]
Inventor(s)01 / KOLLER, Herbert
Quellenstrasse 155A/65
A-1100 Wien / AT
02 / PYERIN, Michael
Enzersdorferstrasse 3/2/8
2345 Brunn am Gebirge / AT
03 / SBROGIÒ, Federico
Via Tecchio 62
36075 Montecchio Maggiore / IT
 [2012/19]
Representative(s)Ricker, Mathias, et al
Wallinger Ricker Schlotter Tostmann
Patent- und Rechtsanwälte Partnerschaft mbB
Zweibrückenstraße 5-7
80331 München / DE
[N/P]
Former [2012/19]Ricker, Mathias, et al
Wallinger Ricker Schlotter Tostmann
Patent- und Rechtsanwälte
Zweibrückenstrasse 5-7
80331 München / DE
Application number, filing date10740144.028.06.2010
WO2010EP03921
Priority number, dateEP2009000846629.06.2009         Original published format: EP 09008466
US20090269766P29.06.2009         Original published format: US 269766 P
[2012/19]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2011000538
Date:06.01.2011
Language:EN
[2011/01]
Type: A1 Application with search report 
No.:EP2448910
Date:09.05.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 06.01.2011 takes the place of the publication of the European patent application.
[2012/19]
Type: B1 Patent specification 
No.:EP2448910
Date:15.05.2013
Language:EN
[2013/20]
Search report(s)International search report - published on:EP06.01.2011
ClassificationIPC:C07C209/62, C07C209/16, C07C211/35
[2012/19]
CPC:
C07C209/62 (EP,US); C07C211/35 (EP,US)
C-Set:
C07C209/62, C07C211/35 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2012/19]
Extension statesBA23.01.2012
ME23.01.2012
RS23.01.2012
TitleGerman:Verfahren zur Herstellung von Neramexan[2012/50]
English:METHOD OF PREPARING NERAMEXANE[2012/19]
French:Procédé de préparation de néramexane[2012/50]
Former [2012/19]VERFAHREN ZUR HERSTELLUNG VON NERAMEXAN
Former [2012/19]PROCÉDÉ DE PRÉPARATION DE NÉRAMEXANE
Entry into regional phase23.01.2012National basic fee paid 
23.01.2012Designation fee(s) paid 
23.01.2012Examination fee paid 
Examination procedure23.01.2012Examination requested  [2012/19]
28.06.2012Amendment by applicant (claims and/or description)
22.11.2012Communication of intention to grant the patent
28.03.2013Fee for grant paid
28.03.2013Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  22.11.2012
Opposition(s)18.02.2014No opposition filed within time limit [2014/17]
Fees paidRenewal fee
30.03.2012Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL15.05.2013
CY15.05.2013
CZ15.05.2013
FI15.05.2013
MC15.05.2013
MK15.05.2013
MT15.05.2013
RO15.05.2013
SM15.05.2013
LU28.06.2013
BG15.08.2013
NO15.08.2013
GR16.08.2013
IS15.09.2013
PT16.09.2013
[2018/46]
Former [2015/34]CY15.05.2013
CZ15.05.2013
FI15.05.2013
MC15.05.2013
MK15.05.2013
MT15.05.2013
RO15.05.2013
SM15.05.2013
LU28.06.2013
BG15.08.2013
NO15.08.2013
GR16.08.2013
IS15.09.2013
PT16.09.2013
Former [2015/32]CY15.05.2013
CZ15.05.2013
FI15.05.2013
MC15.05.2013
MK15.05.2013
MT15.05.2013
RO15.05.2013
SM15.05.2013
BG15.08.2013
NO15.08.2013
GR16.08.2013
IS15.09.2013
PT16.09.2013
Former [2015/30]CY15.05.2013
CZ15.05.2013
FI15.05.2013
MC15.05.2013
MT15.05.2013
RO15.05.2013
SM15.05.2013
BG15.08.2013
NO15.08.2013
GR16.08.2013
IS15.09.2013
PT16.09.2013
Former [2015/24]CZ15.05.2013
FI15.05.2013
MC15.05.2013
MT15.05.2013
RO15.05.2013
SM15.05.2013
BG15.08.2013
NO15.08.2013
GR16.08.2013
IS15.09.2013
PT16.09.2013
Former [2015/13]CZ15.05.2013
FI15.05.2013
MC15.05.2013
MT15.05.2013
RO15.05.2013
BG15.08.2013
NO15.08.2013
GR16.08.2013
IS15.09.2013
PT16.09.2013
Former [2014/14]CZ15.05.2013
FI15.05.2013
MC15.05.2013
RO15.05.2013
BG15.08.2013
NO15.08.2013
GR16.08.2013
IS15.09.2013
PT16.09.2013
Former [2014/11]CZ15.05.2013
FI15.05.2013
RO15.05.2013
BG15.08.2013
NO15.08.2013
GR16.08.2013
IS15.09.2013
PT16.09.2013
Former [2013/50]FI15.05.2013
BG15.08.2013
NO15.08.2013
GR16.08.2013
IS15.09.2013
PT16.09.2013
Former [2013/49]FI15.05.2013
NO15.08.2013
GR16.08.2013
IS15.09.2013
PT16.09.2013
Former [2013/48]NO15.08.2013
IS15.09.2013
PT16.09.2013
Former [2013/47]NO15.08.2013
PT16.09.2013
Cited inInternational search   [XDAI] - DANYSZ W ET AL, "AMINO-ALKYL-CYCLOHEXANS AS A NOVEL CLASS OF UNCOMPETITIVE NMDA RECEPTOR ANTAGONISTS", CURRENT PHARMACEUTICAL DESIGN, BENTHAM SCIENCE PUBLISHERS, NL, (20020101), vol. 8, no. 10, ISSN 1381-6128, pages 835 - 843, XP008030349 [XD] 1,4-7,11 * page 835, column R, paragraph L - page 836, column L, line 8; figure 1 * [A] 2,3,9,10 [I] 8

DOI:   http://dx.doi.org/10.2174/1381612024607117
by applicant   - W. DANYSZ ET AL., CURRENT PHARMACEUTICAL DESIGN, (2002), vol. 8, pages 835 - 843
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.